DKBmed Radio

Dr. Paul Auwaerter discusses COVID-19 vaccine boosters. Topics: *Should your patients get the booster now or wait? *FDA advisory committee votes to include Omicron component in COVID-19 booster vaccines *COVID-19 case and mortality projections for this winter *Booster timing for children and adults  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/7-6-22-episode/eval &nb...

Race and ethnicity. How do they affect a patient’s ability to receive a timely and accurate cystic fibrosis diagnosis? How do the social determinants of health limit access to appropriate CF treatment and produce poorer outcomes?  That’s what we’re here to talk about today with Dr. Jennifer Taylor-Cousar from National Jewish Health and Children’s Hospital Colorado in this  e CysticFibros...

Dr. Paul Auwaerter discusses the current state of COVID-19 including treatment updates. Topics: *Information on new Omicron subvariants *CDC advisory about rebound COVID-19 *Latest treatment information *Post-COVID conditions  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/6-1-22-episode/eval    Access our resource center, download webinar slides, and claim c...

Dr. Paul Auwaerter discusses the effect of the Omicron variant, including its subvariants, on COVID-19 vaccines. Topics: *Impact of Omicron on mRNA boosters *Analyzing Omicron and BA.2 subvariants *Interpreting CDC vaccine data *Protection level of one-way masking  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/5-11-22-episode/eval    Access our resource cent...

Paul G. Auwaerter, MD, MBA, FIDSA and Michael Angarone, DO, FIDSA discuss the latest guidelines for prevention of COVID-19. Topics: *Updates on the BA.2 subvariant *Who should get a second booster? And when? *What conditions and factors place people at higher risk for severe COVID? *Pre-exposure prophylaxis for COVID-19 prevention *Mitigating risk of disease progression    Post-test for...

Paul G. Auwaerter, MD, MBA, FIDSA and David Klimpl, MD discuss current treatments for patients hospitalized with COVID-19. Topics: *New data on efficacy of available therapies *Immunomodulators for critical care patients *Updated NIH recommendations    Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/4-6-22-episode/eval    Access our resource center, downl...

Long-acting injectable antiretroviral therapy is expected to improve adherence, reduce patient burden, and lower community viral load. But for which patients is it suitable? Can it be used as pre-exposure prophylaxis? How does the promise of long-acting ART actually mean in practice?</p><p>Join us for this <em>e</em>HIV Review podcast, as Dr. Tanyaporn Wansom, Senior Infect...

Dr. Paul Auwaerter discusses new vaccine boosters, global impact of the pandemic, and the BA.2 Subvariant. Topics: *New boosters in the future? *Challenges of additional boosters *Cardiac concerns with COVID-19 vaccines? *Collateral effects from the pandemic *Latest news on BA.2 Subvariant  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/4-13-22-episode/eval  &nbsp...

Dr. Paul Auwaerter discusses the BA.2 Subvariant and the recent authorization from the FDA for second booster dose. Topics: *Virulence of BA.2 vs Omicron and Delta * Therapeutic activity of monoclonal antibodies against BA.2 *Details of approval for booster #2 (4th and 5th dose) *Are there advantages to mixing mRNA vaccines?  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecia...

Dr. Paul Auwaerter discusses what we learned from the COVID-19 pandemic. Topics: *Reviewing the timeline of events and variants *What happens next? *Preparing for the future *The new role of monoclonal antibodies  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-24-22-episode/eval    Access our resource center, download webinar slides, and claim credit at htt...

Twenty percent of new HIV diagnoses occur among adolescents and young adults. They’re a population underserved by HIV prevention resources, with lower retention in HIV care. Their awareness and uptake of PrEP has been and remains low. What can their clinicians do to more effectively help these vulnerable young people?   Join Dr. Luis Rubio from University of California San Francisco...

Dr. Paul Auwaerter continues his interview with Dr. Yuka Manabe about COVID-19 testing. Topics: *Future trends in infectious disease diagnostics *Closing the loop with at-home testing *Will treatment replace testing in the future? *Addressing equity of access to diagnostics  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-16-22-episode/eval      Ac...

Stella A. Safo, MD, MPH and Charles Vega, MD discuss how health care providers can improve access to COVID-19 treatment for people from racial/ethnic minority groups. Topics: *Who is receiving treatment for mild to moderate COVID-19? *How the social determinants of health affect COVID-19 risk *Examining COVID-19 outcomes by race and ethnicity *Improving access to treatment   Post-test fo...

Dr. Paul Auwaerter interviews Dr. Yuka Manabe about COVID-19 testing. Topics: *Evaluating COVID-19 testing methods on reliability, speed, and scale *Impact from the Omicron and other variants on testing *Differences between sample types: nasal swab vs saliva *Multiplex and the future of testing *The practical role of serology  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispeci...

Dr. Paul Auwaerter discusses therapeutics, vaccines, and more about emerging variants of COVID-19. Topics: * Changes to NIH recommendations for mild to moderate COVID-19 * New monoclonal antibody: bebtelovimab  * Monoclonal antibody evasion in omicron sublineages * Revisions to booster dose schedules for immunocompromised people   Post-test for CME/CE credit: htt...

Stella Safo, MD, MPH and Michael Angarone, DO, FIDSA discuss how the Omicron variant is impacting COVID-19 treatment decisions. Topics: *Are monoclonal antibodies effective against Omicron and other variants? *Prevalence of the Omicron variant *What are the other variants of concern? *Bob is 70 with lung cancer and SARS-CoV-2 positive - how can you treat him? *Addressing racial inequities &nb...

Dr. Paul Auwaerter discusses reasons to be cautiously optimistic about the future of COVID-19. Topics: *The best ways to stay protected from COVID-19 *Why Omicron is still dangerous *Danger of COVID-19 vs. seasonal flu *What we know about the BA.2 variant *Pros and cons of the Novavax vaccine  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/2-2-22-episode/eval  &nb...

Paul G. Auwaerter, MD, MBA, FIDSA and Charles Vega, MD discuss the latest in COVID-19 treatment news including the Omicron variant. Topics: *Effective treatments for COVID-19 caused by Omicron variant *New antiviral, and other new and in-the-pipeline treatments *Assessing impact of COVID-19 on vulnerable populations and inequities by race/ethnicity *Q&A  Post-test for CME/CE credit: https...

Dr. Paul Auwaerter discusses the COVID-19 Omicron variant. Topics: *Impact on treatment and current spread of Omicron *News on pre-exposure prophylaxis for COVID-19 prevention *With limited supply, how are patients at high risk for severe disease being treated? *Testing for Omicron  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/1-19-22-episode/eval    Access...

Stella Safo, MD, MPH and Aimalohi Ahonkhai, MD, MPH discuss what we can do to address COVID-19 inequities. Topics: *New monoclonal antibody to be used to prevent infection *Latest news on the potential new oral medication *The effect of Omicron on minority populations *Explaining COVID-19 health disparities *Structural barriers to health care and vaccine access    Post-test for CME/CE cr...

Michael Angarone, DO, FIDSA and Charles Vega, MD discuss the latest COVID-19 treatment guidelines and recommendations. Topics: New treatments for COVID-19 Assessing impact of COVID-19 on vulnerable populations and disparities by race/ethnicity Treating patients hospitalized with COVID-19 Live Q&A Post-test for CME/CE credit:  https://covid19.dkbmed.com/multispecialty/12-7-21-episode/eval...

Dr. Paul Auwaerter discusses the COVID-19 variant Omicron. Topics: *Why scientists are concerned about Omicron *More transmissible than Beta and Delta? *Impact on vaccines and treatment *Origin and detection of Omicron *Holiday travel recommendations  Post-test for CME/CE credit:  https://covid19.dkbmed.com/multispecialty/12-1-21-episode/eval    Access...

Shmuel Shoham, MD and Willa V. Cochran, MSN, CRNP discuss how variants are impacting COVID-19 treatment decisions. Topics: *Where are the variants of concern in the US? *Projecting future variant spread *Which monoclonal antibodies are effective for particular variants *Facilitating treatment with monoclonal antibodies  Credit available: 1.0 of AMA, ANCC, AAPA, or ACPE    Post-test...

Dr. Paul Auwaerter discusses current and future COVID-19 treatments. Topics: *Treatments currently in the pipeline *Oral therapies for COVID-19 *Will the current vaccines require periodic boosters? *Possible requirements for oral antiviral use  Post-test for CME/CE credit:  https://covid19.dkbmed.com/multispecialty/11-10-21-episode/eval    Access our resource center,...

Please note, this podcast is not accredited and does not provide continuing education credit.  eMultiple Sclerosis Review Program Director Michael Kornberg, MD discusses on-going MS research with   host Geoff Allix on his UK  “Living Well with MS”  podcast.  Hosted on Acast. See acast.com/privacy for mor...